SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001062822-20-000047
Filing Date
2020-08-04
Accepted
2020-08-03 17:35:38
Documents
14
Period of Report
2020-07-29
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K lxrx-20200729.htm   iXBRL 8-K 35270
  Complete submission text file 0001062822-20-000047.txt   175632

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lxrx-20200729.xsd EX-101.SCH 2426
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lxrx-20200729_cal.xml EX-101.CAL 712
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lxrx-20200729_def.xml EX-101.DEF 1645
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lxrx-20200729_lab.xml EX-101.LAB 23970
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lxrx-20200729_pre.xml EX-101.PRE 12648
7 EXTRACTED XBRL INSTANCE DOCUMENT lxrx-20200729_htm.xml XML 10522
Mailing Address 8800 TECHNOLOGY FOREST PLACE THE WOODLANDS TX 77381
Business Address 8800 TECHNOLOGY FOREST PLACE THE WOODLANDS TX 77381 2818633000
LEXICON PHARMACEUTICALS, INC. (Filer) CIK: 0001062822 (see all company filings)

IRS No.: 760474169 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30111 | Film No.: 201070282
SIC: 2834 Pharmaceutical Preparations